Depixus
2012
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Grant
LATEST DEAL TYPE
$2.4M
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of a technology for extraction of genetic and epigenetic information from single molecules of DNA and RNA. The company's platform SIMDEQ (SIngle-molecule Magnetic DEtection and Quantification) allows for a full genome or genomic region to be analysed quickly and easily on a single integrated platform, with the investigator able to specify the level of sequence and epigenetic detail required, enabling its users with simple sample-preparation, sequential DNA fingerprinting, full-sequencing and epityping, together with a fast time-to-result and low operating costs.
Website
Formerly Known As
PicoSeq
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Primary Office
- 3-5 Impasse Reille
- 75014 Paris
- France
+33 09 00 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Depixus’s full profile, request a free trial.
Depixus Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 15-Jun-2018 | $2.4M | 00.000 | Completed | Startup | |
| 3. Early Stage VC | 29-Mar-2018 | 00.000 | 00.000 | 00.000 | Completed | Startup |
| 2. Early Stage VC | 04-Sep-2017 | $2.33M | $2.33M | 00.000 | Completed | Product Development |
| 1. Accelerator/Incubator | 26-Nov-2013 | Completed | Startup |
Depixus Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Depixus Competitors (23)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ontera Bio | Venture Capital-Backed | Santa Cruz, CA | 000 | 000.00 | 00000000000 | 000.00 |
| 000000 | Venture Capital-Backed | Providence, RI | 00 | 0000 | 0000000000 0 | 0000 |
| 0000000 | Venture Capital-Backed | San Diego, CA | 00 | 00000 | 00000000000 | 00000 |
| 0000000000 | Venture Capital-Backed | South San Francisco, CA | 00 | 0000 | 00000000000 | 0000 |
| 0000 | Private Equity-Backed | Longmont, CO | 00000 | 0000000 0000 | 00000 |
Depixus Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Horizon 2020 | Government | 000 0000 | 000000 0 | |||
| Arix Bioscience | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Agoranov | Accelerator/Incubator | 000 0000 | 000000 0 |
Depixus Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Gordon Hamilton | Co-Founder & Chief Executive Officer | ||
| Chas André | Co-Founder & Chief Technology Officer | ||
| David Bensimon | Co-Founder | ||
| Vincent Croquette | Co-Founder |
Depixus Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Edward Rayner | Arix Bioscience | Board Member | 000 0000 | |
| John Berriman | Self | Chairman | 000 0000 | |
| Ronald Lindsay Ph.D | Self | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 3 of 4 board members. Get the full list »